Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Tobacco Use Disorder × BID protein, human × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Neoplasm Metastasis 2 Vaping 1 Tobacco Use Disorder 1 Stomach Neoplasms 1 Prostatic Neoplasms 1 Peripheral Nervous System Diseases 1 Ovarian Neoplasms 1 Leukemia, Myeloid, Chronic-Phase 1 Leukemia, Myeloid, Acute 1 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 1 Granulosa Cell Tumor 1 Glioblastoma 1 Gastrointestinal Stromal Tumors 1 Carcinoma, Non-Small-Cell Lung 1

Interventions

phenethyl isothiocyanate 1 Varenicline 1 Sulindac 1 Memantine 1 Bupropion 1 BID protein, human 1 Aspirin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07040566 2025-12-17

A Trial of Varenicline for E-cigarette Cessation

Yale University

Phase 2 Recruiting

Vaping, Tobacco Use Disorder

Data powered by HemOnc (CC BY 4.0) Colophon ⚡